| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.031 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |